semaglutide and kidney infection UTI: does GLP-1 therapy increase urinary tract risk? Ozempic Approved for Diabetic Kidney

Renaissance of leptin for obesity therapy

Originally approved for managing blood sugar in type 2 diabetes, recent studies have shown that Mounjaro is also highly beneficial for weight loss and improving metabolic health in overweight or obese individuals, even those without diabetes

For thyroid patients, these results reveal your genetic predisposition to metabolic slowdown and weight gain, helping your PlexusDx physician optimize semaglutide dosing for your unique biology

[4] Semaglutide Protects Liver in T2D with NAFLD A 2025 study concluded that semaglutide provides significant liver benefits in patients with type 2 diabetes (T2D) and nonalcoholic fatty liver disease (NAFLD)